PNPLA3 and metabolic dysfunction-associated steatotic liver disease: However, even in Brazil, the PNPLA3 polymorphisms have also been implicated in liver fibrosis in patients with NAFLD [22, 23, 43] and chronic hepatitis C [28, 38].